Use of infliximab biosimilar in Medicare population is low but growing

7 July 2020 - Slow growth of use of biosimilar infliximab in a Medicare fee-for-service population suggests lingering hesitancy on the ...

Read more →

Abandoning list prices in Medicaid drug reimbursement did not affect spending

7 July 2020 - State fee-for-service Medicaid programs have traditionally based payments to pharmacies for drugs on a percentage of the ...

Read more →

CMS’s proposed Medicaid best price loophole for value based purchasing of drugs

6 July 2020 - For three decades, US pharmaceutical companies have agreed to sell their products to Medicaid programs at ...

Read more →

NICE's evaluations of medicines authorized by EMA with conditional marketing authorization or under exceptional circumstances

25 June 2020 - Products which received conditional marketing authorisation or authorisation in exceptional circumstances by European Medicines Agency up to ...

Read more →

Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients

24 June 2020 - Federal officials on Wednesday alleged that Regeneron Pharmaceuticals donated tens of millions of dollars to a ...

Read more →

MHRA extends access to Santhera's DMD drug via the EAMS

23 June 2020 - The UK’s Medicines and Healthcare products Regulatory Agency has renewed for a further year the Early ...

Read more →

Trump Administration proposes Medicaid reforms to encourage innovative contracting models

22 June 2020 - On Wednesday, June 17, the Centers for Medicare and Medicaid Services proposed a series of reforms ...

Read more →

A mad scramble to stock millions of malaria pills, likely for nothing

16 June 2020 - Before the F.D.A. withdrew its waiver to stockpile the drugs as coronavirus treatments, the Trump administration had ...

Read more →

Statement from Lilly Chairman and CEO Dave Ricks on the new Medicare Part D senior savings model

26 May 2020 - President Donald J. Trump and Seema Verma, Administrator for the Centers for Medicare & Medicaid Services, today ...

Read more →

President Trump announces lower out of pocket insulin costs for Medicare’s seniors

26 May 2020 - Across the nation, 88 Part D Sponsors applied to the Part D Senior Savings Model to offer ...

Read more →

Trump Administration announces changes to Medicare Advantage and Part D to provide better coverage and increase access for Medicare beneficiaries

22 May 2020 - Final Rule continues to strengthen the popular private Medicare health and drug plans. ...

Read more →

Seqirus announces positive CHMP Opinion for its adjuvanted quadrivalent influenza vaccine

31 March 2020 - Seqirus today announced that its adjuvanted quadrivalent influenza vaccine - launching as Fluad Tetra - has received ...

Read more →

Eleven states now letting uninsured sign up for Obamacare

23 March 2020 - More coronavirus care will be covered in many states. Federal officials are considering similar action for the ...

Read more →

COVID-19: an update from Dr. Brian O’Rourke, CADTH President and CEO

18 March 2020 - As our country deals with the COVID-19 situation, CADTH has implemented several initiatives to mitigate the ...

Read more →

Insulin costs may be capped in a Medicare program

11 March 2020 - If drug companies and insurers agree to participate, the Trump administration proposes limiting insulin costs to $35 ...

Read more →